Fabian D Mairinger
Overview
Explore the profile of Fabian D Mairinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lever M, Bogner S, Giousmas M, Mairinger F, Baba H, Richly H, et al.
Pigment Cell Melanoma Res
. 2024 Jul;
37(6):831-838.
PMID: 38994815
Approximately every second patient with uveal melanoma develops distant metastases, with the liver as the predominant target organ. While the median survival after diagnosis of distant metastases is limited to...
2.
Al-Ghazzawi K, Wessolly M, Dalbah S, Ketteler P, Kiefer T, Bechrakis N, et al.
Front Oncol
. 2023 Nov;
13:1144951.
PMID: 37965463
Retinoblastoma (RB) is the most common form of eye cancer experienced in childhood. Its aggressive malignancy is associated with excellent survival rates in high-income countries; however, the prognosis in third-world...
3.
Wyrich M, Ohlig H, Wessolly M, Mairinger E, Steinborn J, Brcic L, et al.
Transl Cancer Res
. 2023 Sep;
12(8):1929-1936.
PMID: 37701096
Background: Malignant pleural mesothelioma (MPM) is an aggressive tumor with a dismal prognosis. Currently, multimodality treatment including chemotherapy with cisplatin or carboplatin in combination with pemetrexed offers the best options....
4.
Borchert S, Mathilakathu A, Nath A, Wessolly M, Mairinger E, Kreidt D, et al.
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569808
The exact mechanism of desmoplastic stromal reaction (DSR) formation is still unclear. The interaction between cancer cells and cancer-associated fibroblasts (CAFs) has an important role in tumor progression, while stromal...
5.
Stephan-Falkenau S, Streubel A, Mairinger T, Blum T, Kollmeier J, Mairinger F, et al.
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37445733
Pulmonary sarcomatoid carcinoma (PSC) has highly aggressive biological behaviour and poor clinical outcomes, raising expectations for new therapeutic strategies. We characterized 179 PSC by immunohistochemistry, next-generation sequencing and in silico...
6.
Al-Ghazzawi K, Mairinger F, Pfortner R, Horstmann M, Bechrakis N, Mohr C, et al.
Life (Basel)
. 2022 Oct;
12(10).
PMID: 36295095
Non-specific orbital inflammation (NSOI) and IgG4-related orbital disease (IgG4-ROD) are currently treated with non-specific immunosuppressive agents based on non-randomized, uncontrolled studies. Therefore, relapses and prolongated courses are common and remain...
7.
Al-Ghazzawi K, Baum S, Pfortner R, Philipp S, Bechrakis N, Gortz G, et al.
Int J Mol Sci
. 2022 Aug;
23(15).
PMID: 35955742
Non-specific orbital inflammation (NSOI) and IgG4-related orbital disease (IgG4-ROD) are often challenging to differentiate. Furthermore, it is still uncertain how chronic inflammation, such as IgG4-ROD, can lead to mucosa-associated lymphoid...
8.
Mathilakathu A, Wessolly M, Mairinger E, Uebner H, Kreidt D, Brcic L, et al.
Int J Mol Sci
. 2022 Mar;
23(6).
PMID: 35328699
Background: Malignant pleural mesothelioma (MPM) has an infaust prognosis due to resistance to systemic treatment with platin-analoga. MPM cells modulate the immune response to their benefit. They release proinflammatory cytokines,...
9.
Wessolly M, Mairinger F, Herold T, Hadaschik B, Szarvas T, Reis H
Genes (Basel)
. 2022 Mar;
13(3).
PMID: 35327977
In recent years, the number and type of treatment options in advanced bladder cancer (BC) have been rapidly evolving. To select an effective therapy and spare unnecessary side effects, predictive...
10.
Wessolly M, Stephan-Falkenau S, Streubel A, Wiesweg M, Borchert S, Mairinger E, et al.
BMC Cancer
. 2022 Jan;
22(1):46.
PMID: 34996407
Background: Immune checkpoint inhibitors (ICIs) are currently one of the most promising therapy options in the field of oncology. Although the first pivotal ICI trial results were published in 2011,...